News
AIxplorerBIO and the Institute of Immunology at Tsinghua University Reached a Strategic Collaboration Agreement to Explore and Promote the R&D of New Drugs in the Field of Autoimmunity
Time: 2022-07-28
Source: Viva Biotech
Share:
[Abstract]:This strategic collaboration, combined with the AIxplorerBio team's rich experience in drug R&D, coupled with the company's comprehensive AI drug discovery platform AIxMol, will position AIxplorerBio at the forefront in the AI drug discovery race to bring better treatment options to patients with autoimmune diseases.

Recently, AIxplorerBIO, which invested and incubated by Viva BioInnovator, reached a strategic collaboration agreement with the Institute of Immunology at Tsinghua University in the field of autoimmunity on the pathogenesis of selected diseases, the selection and validation of relevant targets, and other topics of mutual interests. The two sides held their first pipeline strategy meeting in Beijing on July 19. Professor Xiaoyu Hu, the Executive Director for the Institute, Professors Zhihua Liu and Wenwen Zeng participated in the discussion. This strategic collaboration, combined with the AIxplorerBio team's rich experience in drug R&D, coupled with the company's comprehensive AI drug discovery platform AIxMol, will position AIxplorerBio at the forefront in the AI drug discovery race to bring better treatment options to patients with autoimmune diseases.

Media contact: vivapr@vivabiotech.com
Contact Us